Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in immune modulation.

Carol H Miao1

  • 1Department of Pediatrics, University of Washington & Children's Hospital and Regional Medical Center, Seattle, WA 98101, USA. miao@u.washington.edu

Current Gene Therapy
|November 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of canine hemophilia A via intraosseous delivery of a platelet-specific factor VIII-lentiviral vector.

Blood vessels, thrombosis & hemostasis·2026
Same author

Extracellular vesicles as gatekeepers of antigen trafficking in DNA vaccination.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Exploration of biomarkers for inhibitor development in persons with hemophilia A.

Research and practice in thrombosis and haemostasis·2025
Same author

Rescue of the endogenous FVIII expression in hemophilia A mice using CRISPR-Cas9 mRNA LNPs.

Molecular therapy. Nucleic acids·2024
Same author

Blunting specific T-dependent antibody responses with engineered "decoy" B cells.

Molecular therapy : the journal of the American Society of Gene Therapy·2024
Same author

Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2024
Same journal

Identifying Basement Membrane-Related Diagnostic Biomarkers for Rheumatoid Arthritis Through Machine Learning.

Current gene therapy·2026
Same journal

A Multi-Gene Myofibroblast Framework Stratifies Prognostic and Immune Landscapes in HCC.

Current gene therapy·2026
Same journal

Single-cell Transcriptomics Inference of Neutrophil-mast Cell Communication Programs in Periodontitis.

Current gene therapy·2026
Same journal

GULP1 in Ovarian Cancer: Expression, Biological Function, and Clinical Significance.

Current gene therapy·2026
Same journal

Single‑cell Transcriptomic Profiling of Bone Marrow Mesenchymal Stem Cells Reveals Lineage Heterogeneity and Dysregulated Osteoblast Genes in Osteoporosis Versus Osteoarthritis.

Current gene therapy·2026
Same journal

Surface Functionalization of 3D-Printed Porous Ti-6Al-4V Scaffolds with PDA‑mHA-Col I Composite Coating Drives Macrophage Polarization toward the M2 Phenotype and Promotes Immunomodulation: An In Vitro Study.

Current gene therapy·2026
See all related articles

Gene therapy requires immune hypo-responsiveness to transgene products. This review details strategies for inducing immune tolerance to gene transfer vectors, crucial for successful therapy.

Area of Science:

  • Immunology
  • Gene Therapy
  • Transplantation Immunology

Background:

  • Gene therapy success hinges on immune system hypo-responsiveness to transgene products.
  • Preventing immune responses like cytotoxic T lymphocytes and antibodies is vital for gene transfer vectors.
  • Current non-specific immunosuppressive drugs target T-cell activation and differentiation.

Purpose of the Study:

  • To review strategies for inducing immune tolerance to transgene products in gene therapy.
  • To outline methods for preventing immune reactions against gene transfer vectors.
  • To explore advancements in immune tolerance induction protocols for gene therapy applications.

Main Methods:

  • Review of immune tolerance induction protocols in gene therapy models.

Related Experiment Videos

  • Analysis of central tolerance induction via intrathymic deletion or mixed chimerism.
  • Examination of peripheral tolerance mechanisms: T-cell deletion, apoptosis, anergy, and T regulatory cells.

    • Main Results:

    • Various immune modulation regimens and protocols have been tested.
    • Strategies aim to induce long-term, transgene product-specific immune tolerance.
    • Central and peripheral tolerance induction pathways are explored.

    Conclusions:

    • Achieving immune tolerance is critical for the efficacy and safety of gene therapy.
    • Multiple strategies targeting T-cell responses and regulatory pathways are under development.
    • Further research into immune modulation is essential for advancing gene therapy protocols.